The complexity of TNF-related apoptosis-inducing ligand

被引:0
作者
Abe, K
Kurakin, A
Mohseni-Maybodi, M
Kay, B
Khosravi-Far, R
机构
[1] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02215 USA
[3] Buck Ctr Res Aging, Novato, CA 94945 USA
[4] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA
来源
MECHANISMS OF CELL DEATH II | 2000年 / 926卷
关键词
cancer therapy; TRAIL; TNF superfamily;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
One of the major goals of researchers in the field of apoptosis is to understand the molecular mechanisms of the various components of the apoptotic pathways, with the hope to identify targets for novel cancer therapies. The discovery of a TNF-related, apoptosis-inducing ligand, TRAIL, that kills transformed cells with great specificity in vitro, has provided the hope that TRAIL may be used to induce cell death in tumor cells without affecting normal tissues. However, TRAIL signaling is very complex and a clear understanding of its function is necessary before it can be used in cancer therapy. Complexity of TRAIL-induced signaling is apparent from its ubiquitous expression, its ability to interact with five receptors, and its tumor-selective induction of apoptosis. The signaling events that mediate the tumor selectivity of TRAIL-induced apoptosis and the biological functions of each of the TRAIL receptors are not well characterized. This review will focus on the complexity of TRAIL and the role of c-FLIP in mediating TRAIL function.
引用
收藏
页码:52 / 63
页数:12
相关论文
共 79 条
  • [1] Apoptosis control by death and decoy receptors
    Ashkenazi, A
    Dixit, VM
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) : 255 - 260
  • [2] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [3] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [4] CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
    BANNER, DW
    DARCY, A
    JANES, W
    GENTZ, R
    SCHOENFELD, HJ
    BROGER, C
    LOETSCHER, H
    LESSLAUER, W
    [J]. CELL, 1993, 73 (03) : 431 - 445
  • [5] An essential role for NF-kappa B in preventing TNF-alpha-induced cell death
    Beg, AA
    Baltimore, D
    [J]. SCIENCE, 1996, 274 (5288) : 782 - 784
  • [6] TRAIL receptor-2 signals apoptosis through FADD and caspase-8
    Bodmer, JL
    Holler, N
    Reynard, S
    Vinciguerra, P
    Schneider, P
    Juo, P
    Blenis, J
    Tschopp, J
    [J]. NATURE CELL BIOLOGY, 2000, 2 (04) : 241 - 243
  • [7] Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway
    Chaudhary, PM
    Eby, M
    Jasmin, A
    Bookwalter, A
    Murray, J
    Hood, L
    [J]. IMMUNITY, 1997, 7 (06) : 821 - 830
  • [8] To die or not to die - the quest of the TRAIL receptors
    Degli-Esposti, M
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (05) : 535 - 542
  • [9] The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
    Degli-Esposti, MA
    Dougall, WC
    Smolak, PJ
    Waugh, JY
    Smith, CA
    Goodwin, RG
    [J]. IMMUNITY, 1997, 7 (06) : 813 - 820
  • [10] Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
    DegliEsposti, MA
    Smolak, PJ
    Walczak, H
    Waugh, J
    Huang, CP
    DuBose, RF
    Goodwin, RG
    Smith, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) : 1165 - 1170